AAllergic rhinitis
First line
Allergic rhinitis
First line
First-line treatment for seasonal and perennial allergic rhinitis per ARIA guidelines. Reduces sneezing, rhinorrhea, and nasal/conjunctival itching. Adult dose is 10 mg once daily. Efficacy is comparable to loratadine, though cetirizine causes slightly more drowsiness.
Sources
- J Allergy Clin Immunol: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. (2010)
- J Allergy Clin Immunol: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. (2017)
- Braz J Otorhinolaryngol: Efficacy of different oral H(1) antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials. (2023)
- Allergy: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). (2008)
- AEMPS: Ficha técnica CETIRIZINA CINFA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG (2021)
- Allergy: Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI Guidelines—2024–2025 Revision: Part II (2026)
ICD-10: J30.9 · ICD-11: CA08.0